Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DORZO-TIMOP | 5MG 20MG | SOLUTION SOLUTION | Resolved | 2023-09-22 | 2023-11-24 | 205015 |
| APO-DORZO-TIMOP | 5MG 20MG | SOLUTION SOLUTION | Resolved | 2023-02-16 | 2023-02-23 | 185036 |
| APO-DORZO-TIMOP | 5MG 20MG | SOLUTION SOLUTION | Resolved | 2025-02-06 | 2025-03-21 | 249755 |
| APO-DORZO-TIMOP | 5MG 20MG | SOLUTION SOLUTION | Resolved | 2025-05-08 | 2025-06-06 | 256920 |
| APO-DORZO-TIMOP | 5MG 20MG | SOLUTION | Resolved | 2019-09-25 | 2020-09-04 | 94737 |
| APO-DORZO-TIMOP | 20MG 5MG | SOLUTION SOLUTION | Resolved | 2025-11-13 | 2025-11-28 | 271862 |
| APO-DORZO-TIMOP | 5MG 20MG | SOLUTION SOLUTION | Resolved | 2022-05-20 | 2022-08-06 | 161037 |
| APO-DORZO-TIMOP | 5MG 20MG | SOLUTION | Resolved | 2017-03-10 | 2019-07-13 | 290 |
| APO-DOXAZOSIN | 4MG | TABLET | Resolved | 2025-12-04 | 2025-12-19 | 273333 |
| APO-DOXAZOSIN | 2MG | TABLET | Resolved | 2023-02-23 | 2023-03-23 | 185451 |
| APO-DOXAZOSIN | 1MG | TABLET | Resolved | 2025-05-22 | 2025-07-18 | 258169 |
| APO-DOXAZOSIN | 4MG | TABLET | Resolved | 2018-01-22 | 2018-07-03 | 36812 |
| APO-DOXAZOSIN | 2MG | TABLET | Resolved | 2025-05-15 | 2025-06-27 | 257397 |
| APO-DOXAZOSIN | 4MG | TABLET | Resolved | 2023-12-08 | 2024-03-22 | 212946 |
| APO-DOXAZOSIN | 2MG | TABLET | Resolved | 2020-07-23 | 2020-11-16 | 120982 |
| APO-DOXAZOSIN | 1MG | TABLET | Resolved | 2023-02-09 | 2023-03-23 | 184077 |
| APO-DOXAZOSIN | 4MG | TABLET | Resolved | 2020-02-05 | 2020-04-01 | 105323 |
| APO-DOXEPIN | 50MG | CAPSULE | Resolved | 2017-03-27 | 2017-04-03 | 4389 |
| APO-DOXEPIN | 25MG | CAPSULE | Resolved | 2017-11-21 | 2017-12-08 | 29957 |
| APO-DOXEPIN | 100MG | CAPSULE | Resolved | 2017-03-10 | 2017-04-03 | 298 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 119950 |
| APO-QUININE | 300MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60714 |
| APO-QUININE | 200MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60711 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-08 | 2018-10-05 | 60717 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2018-09-08 | 2019-03-29 | 60720 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60729 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
| APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60747 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64965 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |